LORUSSO, LOREDANA Statistiche
LORUSSO, LOREDANA
DIPARTIMENTO DI MEDICINA CLINICA E SPERIMENTALE
Active surveillance in papillary thyroid microcarcinomas is feasible and safe: experience at one single Italian center
2020-01-01 Molinaro, Eleonora; Campopiano, Maria Cristina; Pieruzzi, Letizia; Matrone, Antonio; Agate, Laura; Bottici, Valeria; Viola, David; Cappagli, Virginia; Valerio, Laura; Giani, Carlotta; Puleo, Luciana; Lorusso, Loredana; Piaggi, Paolo; Torregrossa, Liborio; Basolo, Fulvio; Vitti, Paolo; Tuttle, R Michael; Elisei, Rossella
Ca19.9 positivity and doubling time are prognostic factors of mortality in patients with advanced medullary thyroid cancer with no evidence of structural disease progression according to RECIST
2021-01-01 Lorusso, Loredana; Romei, Cristina; Piaggi, Paolo; Fustini, Chiara; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Viola, David; Pellegrini, Giovanni; Elisei, Rossella
Carcinoma tiroideo e gravidanza.
2013-01-01 L., Agate; Lorusso, Loredana; Molinaro, Eleonora; Elisei, Rossella
Hypertension, nausea, anorexia and weight loss were significantly associated with better progression-free survival in patients with radioiodine-Refractory Differentiated Thyroid Carcinoma treated with Lenvatinib
2018-01-01 Giani, C.; Valerio, L.; Pieruzzi, L.; Agate, L.; Viola, D.; Bottici, V.; Piaggi, P.; Lorusso, L.; Cappagli, V.; Puleo, L.; Matrone, A.; Mazzeo, S.; Ribechini, A.; Vitti, P.; Molinaro, E.; Elisei, Rossella
Il carcinoma tiroideo: nuove prospettive terapeutiche.
2014-01-01 Viola, David; Agate, Laura; Molinaro, Eleonora; Bottici, Valeria; Lorusso, Loredana; Valerio, Laura; Matrone, Antonio; Biagini, Agnese; Cappagli, Virginia; Giani, Carlotta; Pieruzzi, Letizia; Contillo, Benedetta Pontillo; Battaglia, Valentina; Mazzeo, Salvatore; Elisei, Rossella
Influence of Lymphocytic Thyroiditis at Histology and Serum Thyroglobulin Autoantibodies on the Course of Papillary Thyroid Carcinoma
2020-01-01 Viola, Nicola; Agate, Laura; Caprio, Sonia; Ricci, Debora; Brancatella, Alessandro; Sgro', Daniele; Marino', Michele; Vitti, Paolo; Elisei, Rossella; Piaggi, Paolo; Lorusso, Loredana; Ugolini, Clara; Latrofa, Francesco
Lenvatinib and other tyrosine kinase inhibitors for the treatment of radioiodine refractory, advanced, and progressive thyroid cancer
2016-01-01 Lorusso, Loredana; Pieruzzi, Letizia; Biagini, Agnese; Sabini, Elena; Valerio, Laura; Giani, Carlotta; Passannanti, PAOLO FRANCESCO; PONTILLO CONTILLO, Benedetta; Battaglia, Valentina; Mazzeo, Salvatore; Molinaro, Eleonora; Elisei, Rossella
Lenvatinib therapy in progressive, radioiodine-refractory, differentiated thyroid carcinoma: analysis of 74 cases followed in a single centre
2018-01-01 Giani, C; Valerio, L; Pieruzzi, L; Agate, L; Viola, D; Bottici, V; Piaggi, P; Lorusso, L; Cappagli, V; Puleo, L; Matrone, A; Mazzeo, S; Pontillo-Contillo, B; Ribechini, A; Vitti, P; Molinaro, E; Elisei, R.
Lenvatinib treatment in the real clinical practice of progressive, radioiodine-refractory differentiated thyroid carcinoma: analysis of a big series followed in a single center
2019-01-01 Giani, Carlotta; Valerio, Laura; Agate, Laura; Viola, David; Bottici, Valeria; Lorusso, Loredana; Cappagli, Virginia; Matrone, Antonio; Materazzi, Gabriele; Mazzeo, Salvatore; Ribechini, Alessandro; Vitti, Paolo; Molinaro, Eleonora; Elisei, Rossella
Less than 2% of the low- and intermediate-risk differentiated thyroid cancers show distant metastases at post-ablation whole-body scan
2019-01-01 Agate, L.; Bianchi, Francesca; Brozzi, F.; Santini, P.; Molinaro, E.; Bottici, V.; Viola, D.; Lorusso, L.; Vitti, P.; Elisei, R.
Lung recurrence of papillary thyroid cancer diagnosed with antithyroglobulin antibodies after 10 years from initial treatment.
2018-01-01 Viola, D; Agate, L; Molinaro, E; Bottici, V; Lorusso, L; Latrofa, F; Torregrossa, L; Boldrini, L; Ramone, Teresa; Vitti, P; Elisei, R.
MON-490 Calcitonin-Based Thyroidectomy Is a Safe Approach in Patients with Germline RET Mutation and Permits to Delay Surgery in Children
2020-01-01 Prete, A; Romei, C; Tacito, A; Ramone, T; Bottici, V; Cappagli, V; Viola, D; Matrone, A; Agate, L; Lorusso, L; Valerio, L; Giani, C; Puleo, L; Molinaro, E; Elisei, R.
Next generation sequencing revealed RET or RAS mutation in medullary thyroid cancer that were negative at sanger sequencing
2018-01-01 Romei, Cristina; Ciampi, Raffaele; Ramone, Teresa; Tacito, Alessia; Cappagli, Virginia; Lorusso, Loredana; Giani, Carlotta; Valerio, Laura; Elisei, Rossella
No difference in the outcome of metastatic thyroid cancer patients when using recombinant or endogenous TSH
2020-01-01 Campopiano, Maria Cristina; Podestà, Debora; Bianchi, Francesca; Giani, Carlotta; Agate, Laura; Bottici, Valeria; Cappagli, Virginia; Lorusso, Loredana; Matrone, Antonio; Puleo, Luciana; Valerio, Laura; Viola, David; Piaggi, Paolo; Elisei, Rossella; Molinaro, Eleonora
Osteonecrosis of the jaw: a rare but possible side effect in thyroid cancer patients treated with tyrosine-kinase inhibitors and bisphosphonates
2021-01-01 Lorusso, L.; Pieruzzi, L.; Gabriele, M.; Nisi, M.; Viola, D.; Molinaro, E.; Bottici, V.; Elisei, R.; Agate, L.
Prevalence and Risk Factors of Developing Fistula or Organ Perforation in Patients Treated with Lenvatinib for Radioiodine-Refractory Thyroid Cancer
2021-01-01 Valerio, L.; Giani, C.; Agate, L.; Molinaro, E.; Viola, D.; Bottici, V.; Matrone, A.; Puleo, L.; Lorusso, L.; Cappagli, V.; Ribechini, A.; Elisei, R.
Protein kinase inhibitors for the treatment of advanced and progressive radiorefractory thyroid tumors: From the clinical trials to the real life
2017-01-01 Matrone, Antonio; Valerio, Laura; Pieruzzi, Letizia; Giani, Carlotta; Cappagli, Virginia; Lorusso, Loredana; Agate, Laura; Puleo, Luciana; Viola, David; Bottici, Valeria; Del Re, Marzia; Molinaro, Eleonora; Danesi, Romano; Elisei, Rossella
RET mutated C-cells proliferate more rapidly than non-mutated neoplastic cells
2021-01-01 Romei, Cristina; Ramone, Teresa; Mulè, Chiara; Prete, Alessandro; Cappagli, Virginia; Lorusso, Loredana; Torregrossa, Liborio; Basolo, Fulvio; Ciampi, Raffele; Elisei, Rossella
Risultati dello studio di fase III, randomizzato, controllato, in doppio cieco, Sorafenib vs Placebo nel trattamento del carcinoma differenziato della tiroide (CDT) localmente avanzato o metastatico, refrattario al 131I, in progressione.
2013-01-01 Agate, L.; Lorusso, L.; Pacini, F.; Fugazzola, L.; Licitra, L.; Siena, S.; Puxeddu, E.; Giuffrida, D.; Colao, Am; Elisei, R.
Systemic treatment of advanced, metastatic, medullary thyroid carcinoma
2021-01-01 Matrone, Antonio; Gambale, Carla; Prete, Alessandro; Cappagli, Virginia; Lorusso, Loredana; Bottici, Valeria; Elisei, Rossella
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Active surveillance in papillary thyroid microcarcinomas is feasible and safe: experience at one single Italian center | 1-gen-2020 | Molinaro, Eleonora; Campopiano, Maria Cristina; Pieruzzi, Letizia; Matrone, Antonio; Agate, Laura; Bottici, Valeria; Viola, David; Cappagli, Virginia; Valerio, Laura; Giani, Carlotta; Puleo, Luciana; Lorusso, Loredana; Piaggi, Paolo; Torregrossa, Liborio; Basolo, Fulvio; Vitti, Paolo; Tuttle, R Michael; Elisei, Rossella | |
| Ca19.9 positivity and doubling time are prognostic factors of mortality in patients with advanced medullary thyroid cancer with no evidence of structural disease progression according to RECIST | 1-gen-2021 | Lorusso, Loredana; Romei, Cristina; Piaggi, Paolo; Fustini, Chiara; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Viola, David; Pellegrini, Giovanni; Elisei, Rossella | |
| Carcinoma tiroideo e gravidanza. | 1-gen-2013 | L., Agate; Lorusso, Loredana; Molinaro, Eleonora; Elisei, Rossella | |
| Hypertension, nausea, anorexia and weight loss were significantly associated with better progression-free survival in patients with radioiodine-Refractory Differentiated Thyroid Carcinoma treated with Lenvatinib | 1-gen-2018 | Giani, C.; Valerio, L.; Pieruzzi, L.; Agate, L.; Viola, D.; Bottici, V.; Piaggi, P.; Lorusso, L.; Cappagli, V.; Puleo, L.; Matrone, A.; Mazzeo, S.; Ribechini, A.; Vitti, P.; Molinaro, E.; Elisei, Rossella | |
| Il carcinoma tiroideo: nuove prospettive terapeutiche. | 1-gen-2014 | Viola, David; Agate, Laura; Molinaro, Eleonora; Bottici, Valeria; Lorusso, Loredana; Valerio, Laura; Matrone, Antonio; Biagini, Agnese; Cappagli, Virginia; Giani, Carlotta; Pieruzzi, Letizia; Contillo, Benedetta Pontillo; Battaglia, Valentina; Mazzeo, Salvatore; Elisei, Rossella | |
| Influence of Lymphocytic Thyroiditis at Histology and Serum Thyroglobulin Autoantibodies on the Course of Papillary Thyroid Carcinoma | 1-gen-2020 | Viola, Nicola; Agate, Laura; Caprio, Sonia; Ricci, Debora; Brancatella, Alessandro; Sgro', Daniele; Marino', Michele; Vitti, Paolo; Elisei, Rossella; Piaggi, Paolo; Lorusso, Loredana; Ugolini, Clara; Latrofa, Francesco | |
| Lenvatinib and other tyrosine kinase inhibitors for the treatment of radioiodine refractory, advanced, and progressive thyroid cancer | 1-gen-2016 | Lorusso, Loredana; Pieruzzi, Letizia; Biagini, Agnese; Sabini, Elena; Valerio, Laura; Giani, Carlotta; Passannanti, PAOLO FRANCESCO; PONTILLO CONTILLO, Benedetta; Battaglia, Valentina; Mazzeo, Salvatore; Molinaro, Eleonora; Elisei, Rossella | |
| Lenvatinib therapy in progressive, radioiodine-refractory, differentiated thyroid carcinoma: analysis of 74 cases followed in a single centre | 1-gen-2018 | Giani, C; Valerio, L; Pieruzzi, L; Agate, L; Viola, D; Bottici, V; Piaggi, P; Lorusso, L; Cappagli, V; Puleo, L; Matrone, A; Mazzeo, S; Pontillo-Contillo, B; Ribechini, A; Vitti, P; Molinaro, E; Elisei, R. | |
| Lenvatinib treatment in the real clinical practice of progressive, radioiodine-refractory differentiated thyroid carcinoma: analysis of a big series followed in a single center | 1-gen-2019 | Giani, Carlotta; Valerio, Laura; Agate, Laura; Viola, David; Bottici, Valeria; Lorusso, Loredana; Cappagli, Virginia; Matrone, Antonio; Materazzi, Gabriele; Mazzeo, Salvatore; Ribechini, Alessandro; Vitti, Paolo; Molinaro, Eleonora; Elisei, Rossella | |
| Less than 2% of the low- and intermediate-risk differentiated thyroid cancers show distant metastases at post-ablation whole-body scan | 1-gen-2019 | Agate, L.; Bianchi, Francesca; Brozzi, F.; Santini, P.; Molinaro, E.; Bottici, V.; Viola, D.; Lorusso, L.; Vitti, P.; Elisei, R. | |
| Lung recurrence of papillary thyroid cancer diagnosed with antithyroglobulin antibodies after 10 years from initial treatment. | 1-gen-2018 | Viola, D; Agate, L; Molinaro, E; Bottici, V; Lorusso, L; Latrofa, F; Torregrossa, L; Boldrini, L; Ramone, Teresa; Vitti, P; Elisei, R. | |
| MON-490 Calcitonin-Based Thyroidectomy Is a Safe Approach in Patients with Germline RET Mutation and Permits to Delay Surgery in Children | 1-gen-2020 | Prete, A; Romei, C; Tacito, A; Ramone, T; Bottici, V; Cappagli, V; Viola, D; Matrone, A; Agate, L; Lorusso, L; Valerio, L; Giani, C; Puleo, L; Molinaro, E; Elisei, R. | |
| Next generation sequencing revealed RET or RAS mutation in medullary thyroid cancer that were negative at sanger sequencing | 1-gen-2018 | Romei, Cristina; Ciampi, Raffaele; Ramone, Teresa; Tacito, Alessia; Cappagli, Virginia; Lorusso, Loredana; Giani, Carlotta; Valerio, Laura; Elisei, Rossella | |
| No difference in the outcome of metastatic thyroid cancer patients when using recombinant or endogenous TSH | 1-gen-2020 | Campopiano, Maria Cristina; Podestà, Debora; Bianchi, Francesca; Giani, Carlotta; Agate, Laura; Bottici, Valeria; Cappagli, Virginia; Lorusso, Loredana; Matrone, Antonio; Puleo, Luciana; Valerio, Laura; Viola, David; Piaggi, Paolo; Elisei, Rossella; Molinaro, Eleonora | |
| Osteonecrosis of the jaw: a rare but possible side effect in thyroid cancer patients treated with tyrosine-kinase inhibitors and bisphosphonates | 1-gen-2021 | Lorusso, L.; Pieruzzi, L.; Gabriele, M.; Nisi, M.; Viola, D.; Molinaro, E.; Bottici, V.; Elisei, R.; Agate, L. | |
| Prevalence and Risk Factors of Developing Fistula or Organ Perforation in Patients Treated with Lenvatinib for Radioiodine-Refractory Thyroid Cancer | 1-gen-2021 | Valerio, L.; Giani, C.; Agate, L.; Molinaro, E.; Viola, D.; Bottici, V.; Matrone, A.; Puleo, L.; Lorusso, L.; Cappagli, V.; Ribechini, A.; Elisei, R. | |
| Protein kinase inhibitors for the treatment of advanced and progressive radiorefractory thyroid tumors: From the clinical trials to the real life | 1-gen-2017 | Matrone, Antonio; Valerio, Laura; Pieruzzi, Letizia; Giani, Carlotta; Cappagli, Virginia; Lorusso, Loredana; Agate, Laura; Puleo, Luciana; Viola, David; Bottici, Valeria; Del Re, Marzia; Molinaro, Eleonora; Danesi, Romano; Elisei, Rossella | |
| RET mutated C-cells proliferate more rapidly than non-mutated neoplastic cells | 1-gen-2021 | Romei, Cristina; Ramone, Teresa; Mulè, Chiara; Prete, Alessandro; Cappagli, Virginia; Lorusso, Loredana; Torregrossa, Liborio; Basolo, Fulvio; Ciampi, Raffele; Elisei, Rossella | |
| Risultati dello studio di fase III, randomizzato, controllato, in doppio cieco, Sorafenib vs Placebo nel trattamento del carcinoma differenziato della tiroide (CDT) localmente avanzato o metastatico, refrattario al 131I, in progressione. | 1-gen-2013 | Agate, L.; Lorusso, L.; Pacini, F.; Fugazzola, L.; Licitra, L.; Siena, S.; Puxeddu, E.; Giuffrida, D.; Colao, Am; Elisei, R. | |
| Systemic treatment of advanced, metastatic, medullary thyroid carcinoma | 1-gen-2021 | Matrone, Antonio; Gambale, Carla; Prete, Alessandro; Cappagli, Virginia; Lorusso, Loredana; Bottici, Valeria; Elisei, Rossella |